31 May 2017

On the way to recovery

The Vidi programme targets excellent researchers with several years of experience after their PhD. These researchers belong to the best of their respective disciplines. The Vidi programme enables them to do research for five years, which is how NWO hopes to stimulate innovation in science.

Vidi grant for Vivian Weerdesteyn - Theme Disorders of movement
Following a stroke, humans often struggle with balance and walking. This impacts their  safety and autonomy tremendously, which is a problem especially in our aging society. It is still unknown how different neural pathways contribute to the recovery of balance and walking after a stroke. Dr. Weerdesteyn and her colleagues are going to change this. They will furthermore attempt to facilitate recovery through training in order to improve functioning in daily life.

> see the personal page of Vivian Weerdesteyn for more information about her research

 

More information


Researcher profile

Vivian Weerdesteyn PhD

Related news items


Lowering cholesterol is not enough to reduce hyperactivity of the immune system

14 June 2019

In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.

read more

New cause for vaginal yeast infections discovered

13 June 2019

Martin Jaeger, theme Infectious diseases and global health, and colleagues, identified SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Their findings were published in Science Translational Medicine.

read more

Internal KWF review procedure 2020

13 June 2019

In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

read more

A personal touch of Johan van der Vlag

13 June 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Johan van der Vlag.

read more

Peter van der Kraan new theme leader Inflammatory diseases

13 June 2019

It is our pleasure to introduce Peter van der Kraan from the Dept. of Rheumatology, as the new leader of our theme Inflammatory diseases. As such he will be the successor of Irma Joosten who has done an outstanding job in the last years as theme leader, for which we thank her wholeheartedly.

read more

Intake of a reduced dose of pazopanib with food the effect on pharmacokinetics, patient safety and preference

13 June 2019

In Clinical Pharmacology & Therapeutics Floor Lubberman and colleagues showed that the intake of 600mg pazopanib with food resulted in a bioequivalent exposure and was preferred over a standard pazopanib dose without food.

read more